Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.100
+0.020 (1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
1.100
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT

Alzamend Neuro Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Jan '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2020 - 2016
Selling, General & Admin
3.393.083.487.427.123.64
Upgrade
Research & Development
3.651.416.467.455.21.31
Upgrade
Operating Expenses
7.034.59.9414.8712.324.95
Upgrade
Operating Income
-7.03-4.5-9.94-14.87-12.32-4.95
Upgrade
Interest Expense
-0.01-0.02-0.01-0.01-0.05-0.16
Upgrade
Interest & Investment Income
-----0
Upgrade
EBT Excluding Unusual Items
-7.04-4.51-9.95-14.88-12.37-5.11
Upgrade
Other Unusual Items
----00.06
Upgrade
Pretax Income
-7.04-4.51-9.95-14.88-12.36-5.05
Upgrade
Net Income
-7.04-4.51-9.95-14.88-12.36-5.05
Upgrade
Preferred Dividends & Other Adjustments
0.50.59----
Upgrade
Net Income to Common
-7.54-5.11-9.95-14.88-12.36-5.05
Upgrade
Shares Outstanding (Basic)
300000
Upgrade
Shares Outstanding (Diluted)
300000
Upgrade
Shares Change (YoY)
765.27%499.67%4.07%9.45%22.64%1.96%
Upgrade
EPS (Basic)
-2.99-11.32-132.33-205.97-187.31-93.78
Upgrade
EPS (Diluted)
-2.99-11.32-132.33-205.97-187.31-93.78
Upgrade
Free Cash Flow
-6.17-6.87-8.42-8.92-6.72-2.71
Upgrade
Free Cash Flow Per Share
-2.45-15.24-111.97-123.53-101.83-50.40
Upgrade
EBITDA
-6.94-4.45-9.89-14.85-12.32-
Upgrade
D&A For EBITDA
0.10.050.050.020-
Upgrade
EBIT
-7.03-4.5-9.94-14.87-12.32-4.95
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.